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Oligodendrocyte Population Dynamics
and the Role of PDGF In Vivo
al., 1994). In the embryonic spinal cord, the first O-2A
progenitors are generated in a specialized part of the
ventral neuroepithelium and subsequently proliferate
Andrew R. Calver,1,6 Anita C. Hall,1,6,7
Wei-Ping Yu,1,8 Frank S. Walsh,4
John K. Heath,3 Christer Betsholtz,2
and disperse evenly throughout the cord (reviewed byand William D. Richardson1,5
Miller, 1996; Richardson et al., 1997). Subsequently,1MRC Laboratory for Molecular Cell Biology
postmitotic oligodendrocytes appear first in the ventraland Department of Biology
axon tracts and then in the dorsal and lateral tractsUniversity College London
(developing white matter) (Jordan et al., 1989; Yu et al.,Gower Street
1994; this paper). It is not known how oligodendrocyteLondon WC1E 6BT
number is controlled during development nor whatUnited Kingdom
causes them to accumulate selectively in axon tracts2Department of Medical Biochemistry
even though their progenitor cells are not concentratedUniversity of GoÈ teborg
there. It seems likely that signaling between neuronsMedicinaregaten 9
and oligodendrocytesand/or theirprogenitors must playGoÈ teborg S-413 90
a role in the establishment and maintenance of theirSweden
specific interactions (Levine, 1989; Barres and Raff,3School of Biochemistry
1994; Burne et al., 1996). For example, it is reported thatUniversity of Birmingham, Edgbaston
axons stimulate division of oligodendrocyte progenitorBirmingham B15 2TT
cells and that this depends on whether they are electri-United Kingdom
cally active (Barres and Raff, 1993). Electrical activity4Department of Neuroscience Research
might stimulate production or release of polypeptide
SmithKline Beecham Pharmaceuticals
mitogens either from the axons themselvesor from other
Harlow, Essex CM19 5AW cells (e.g., astrocytes) in their vicinity (Barres and Raff,
United Kingdom 1993). Axons are also thought to be required for oligo-
dendrocyte survival (Barres et al., 1993).
A prime candidate for a neuron-derived mitogen is
Summary platelet-derived growth factor (PDGF), which is ex-
pressed by many neurons throughout the developing
Oligodendrocyte progenitors originate near the floor CNS (Yeh et al., 1991; Sasahara et al., 1991) and is
plate of the spinal cord, then proliferate and migrate known to be a potent mitogen for O-2A progenitors in
throughout the cord before giving rise to oligodendro- vitro (Noble et al., 1988; Richardson et al., 1988; Levine,
cytes. Progenitor cell proliferation stops before birth 1989). To test the role of PDGF in vivo, we examined
because the cell cycle slows down, linked to an in- PDGF knockout mice. There was a severe reduction in
crease in differentiation and death. Experiments with the number of O-2A progenitors and oligodendrocytes
transgenic mice show that platelet-derived growth in the spinal cords of mice lacking PDGF-A, but not in
factor (PDGF) drives progenitor cell division and sug- mice lacking PDGF-B, implicating PDGF-AA homodi-
mers in the control of progenitor cell proliferation in vivo.gest that slowing of and exit from the cycle reflects a
We also generated transgenic mice that overexpressdecline in PDGF signaling. Overexpressing PDGF in-
PDGF-A in neurons, inducing hyperproliferation of oligo-duces hyperproliferation of progenitor cells and exces-
dendrocyte progenitors and increasing their numberssive, ectopic production of oligodendrocytes. However,
up to 7-fold. This resulted in secondary overproductionthe superfluous oligodendrocytes die at an immature
of oligodendrocytes, many of which were abnormallystage of differentiation, leaving a normal complement
located in gray matter. However, the extra, ectopic oligo-of myelin-forming cells. Therefore, cell survival con-
dendrocytes were all eliminated by programmed celltrols override proliferation controls for determining the
death at an immature stage of development so that thefinal number and distribution of mature oligodendro-
final number and distribution of mature oligodendro-cytes.
cytes was completely normal. These data demonstrate
the dominance of cell survival controls over cell prolifer-Introduction
ation controls for determining the final number and spa-
tial arrangement of postmitotic oligodendrocytes. OurOligodendrocytes are generated during embryonic and
data also suggest that the time at which myelinatingearly postnatal life by differentiation of proliferative mi-
oligodendrocytes start to appear in axon tracts mightgratory glial progenitor cells known as O-2A progenitors
depend on the timed appearance of survival signals, not(Raff et al., 1983; for reviews see Raff, 1989; Pfeiffer et
timed differentiation per se.
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7 Present address: Developmental Biology Research Centre, The
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In this paper we have used the term ªproliferationº to5RL, UK
mean increase in number, not as a synonym for ªdivide.º8 Present address: Institute of Molecular and Cell Biology, National
University of Singapore, 10 Kent Ridge Crescent, Singapore 0511. It is possible for progenitor cells to stop proliferating
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Figure 1. PDGF-A Is Required for Normal
Proliferation of Oligodendrocyte Progenitors
in the Spinal Cord
Sections were cut through the upper thoracic
spinal cords of E17 homozygous PDGF-A
knockout mice orwild-type littermates. These
were hybridized with a 35S-labeled RNA probe
against PDGFRa, autoradiographed, and pho-
tographed under dark-field illumination. Each
white dot within the spinal cord represents
a cluster of silver grains overlying a single
progenitor cell. In PDGF-A-null cords (top
right) there were less than 5% of the normal
number of progenitors compared to wild type
(top left). The lack of progenitor cells in PDGF-
A-null mice was not caused by premature dif-
ferentiation into oligodendrocytes because
there were very few cells positive for the my-
elin PLP mRNA (e.g., arrows) in either PDGF-
A-null (bottom right) or wild-type cords (bot-
tom left) at this age. The prominent structure
lying above the spinal cord in the bottom-
left panel is a cross-section through a blood
vessel, which gives a false positive signal due
to light scattering by red blood cells. Scale
bar 5 100 mm.
while continuing to divide if half of the newly formed few oligodendrocytes develop in cultures of spinal cord
cells that have been depleted of PDGFRa1 cells by anti-cells are lost from the population each generation by
differentiation and/or death. We define ªdifferentiationº body-mediated complement lysis (Hall et al., 1996). Note
that PDGFRa is rapidly downregulated after progenitorsas a lengthy process starting at the moment progenitor
cells exit the cell cycle, continuing until the oligodendro- stop dividing and start to differentiate (Hart et al., 1989;
Hall et al., 1996). Therefore, the PDGFRa expressioncytes myelinate axons. Therefore, if a progenitor cell
exits the division cycle into G0 and immediately dies, we pattern reflects the distribution of O-2A progenitors, not
differentiated oligodendrocytes. PDGFRa is also ex-regard that as death of a newly formed oligodendrocyte,
even if the postmitotic cell did not survive long enough pressed by cells in meningeal membranes and by many
tissues outside the CNS (Orr-Urtreger and Lonai, 1992).to express recognizable oligodendrocyte markers such
as GC or PLP/DM-20. In PDGF-A-null spinal cords, the first O-2A progenitors
appeared as normal at the luminal surface on E12.5,
showing that PDGF-A is not required for initial specifica-PDGF-AA Homodimers Are Required for Proliferation
of O-2A Progenitor Cells in the Spinal Cord tion of the oligodendrocyte lineage (data not shown).
However, they did not proliferate normally after this; atActive PDGF consists of homodimers of A and B chains
(AA, BB, AB), all of which can bind to and activate all ages examined up to postnatal day 19 (P19) there
were fewer than 10% of the normal number of O-2APDGFRa on O-2A progenitor cells (Heldin et al., 1988;
Hart et al., 1989; Pringle et al., 1989). Many studies have progenitors in spinal cords of PDGF-A-null mice com-
pared to their wild-type littermates. For example, weshown that PDGF can influence oligodendrocyte devel-
opment both in vitro and in vivo, but as yet there has counted 236 6 35 progenitors/section in E17 wild-type
cords and 12 6 8 in PDGF-A-null cords (mean 6 SDbeen no confirmation that PDGF is necessary in vivo.
We therefore investigated early development of the oli- of three sections from each of two embryos of each
genotype) (Figure 1). We do not know whether the failuregodendrocyte lineage in transgenic mice with targeted
disruptions of the PDGF-A or PDGF-B gene. to proliferate in the absence of PDGF-A reflects a de-
crease in cell division or an increase in death or both.Newborn PDGF-A2/2 mice are outwardly normal but
fail to thrive after birth. Most die within a few days of However, the lack of progenitors was not caused by
premature generation of mature oligodendrocytes be-birth, but rare individuals survive for as long as three
weeks, eventually dying of pulmonary failure (BostroÈ m cause in situ hybridization with probes for RNA tran-
scripts coding for proteolipid protein (PLP; Figure 1) oret al., 1996). We visualized O-2A progenitor cells in spinal
cords of PDGF-A2/2 embryos and neonates and their myelin basic protein (MBP; data not shown) showed that
there was very little mature oligodendrocyte productionwild-type littermates by in situ hybridization with a probe
against PDGFRa mRNA. We and others have shown before birth in either wild-type or mutant spinal cords.
The loss of PDGF-A in the knockouts does not causethat PDGFRa marks O-2A progenitors in the perinatal
rodent optic nerve (Hart et al., 1989), spinal cord (Yu et general downregulation of PDGFRa mRNA because
there was no change in the intensity of the PDGFRaal., 1994; Hall et al., 1996; Nishiyama et al., 1996) and
brain (Ellison and de Vellis, 1994). For example, when signal in the many tissues that express this gene outside
of the CNS. Also, longer exposures of the in situ autora-PDGFRa1 cells are immunoselected from embryonic
day 17 (E17) rat spinal cords and cultured in defined diographs failed to reveal any additional PDGFRa1 pro-
genitor cells in the knockout spinal cord.medium, they all give rise to oligodendrocytes, and very
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Figure 2. Proliferation of Oligodendrocyte Progenitors in Normal and Transgenic Spinal Cords Ceases after E15
(A) Sections through the upper thoracic spinal cord were subjected to in situ hybridization with a probe to PDGFRa as in Figure 1. In wild-
type cords (left panels) the number of progenitor cells increased rapidly between E12.5 (arrow) and E15, but the rate of increase slowed down
substantially after that, arresting between E15 and E17 (see [B]). In hemizygous NSE-PDGF-AS transgenic cords (right panels; see Figure 3),
progenitor cell number was normal up until E13.5, but approximately three times the normal number of progenitors developed between E13.5
and E15, and this increase persisted until later times. Scale bar 5 100 mm.
(B) Numbers of PDGFRa1 progenitors in sections of spinal cords of hemizygous transgenic NSE-PDGF-AS mice (squares) and their wild-type
littermates (triangles). Data is plotted as mean 6 SD of counts of three or four sections from each of two animals of each age and genotype
from separate litters. Cells stop proliferating between E15 and E17 in both wild-type and transgenic cords.
PDGF-B2/2 mice have defective kidneys and capillary number of cells per section increases rapidly between
E12.5 and E15 (Figures2A and 2B, black triangles). Then,blood vessels; they are hemorrhagic and invariably die
around birth (LeveeÂn et al., 1994; Lindahl et al., 1997). the number of cells reaches a plateau between E15
and E17 that persists until at least P3 (Figure 2B, blackIn spinal cords of PDGF-B2/2 mice, the number and
distribution of O-2A progenitors was normal up to and triangles). Since there is normally very little oligodendro-
cyte production before birth (Figure 1), it follows thatincluding the day of birth (data not shown). We conclude
that PDGF-AA (not AB or BB) is crucial for driving prolif- the number of O-2A progenitors must be held constant
either by cessation of cell division or by a balance be-eration of O-2A progenitors during normal development.
A more complete description of the CNS phenotypes of tween division and death. Further experiments (see be-
low) showed that the cell cycle slows down markedlyPDGF-null mice will be presented elsewhere.
and there is also an increase in cell death.
O-2A Progenitors Stop Proliferating Several
Days before Birth
As a prelude to studies of PDGF-A overexpression in Proliferation Arrest Results from Slowing
of the Cell Cycle Coupled to antransgenic mice (see below), we counted the numbers
of PDGFRa1 O-2A progenitors in autoradiographs of Increase in Cell Death
We compared the rate of O-2A progenitor cell cyclingsections through wild-type spinal cords at various stages
of embryonic and early postnatal development. The in normal embryos before and after they had stopped
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proliferating by bromodeoxyuridine (BrdU)-labeling ex-
periments in vivo. In one series of experiments, we gave
a single intraperitoneal injection of BrdU to the mother,
removed the embryos 2 hr later, and determined the
proportion of O-2A progenitors that had incorporated
BrdU. We identified progenitors by dissociating spinal
cord cells, culturing them overnight on coverslips in
the presence of PDGF-AA, and labeling with antibodies
against the chondroitin sulphate proteoglycan NG2, a
surface marker of oligodendrocyte progenitors (Stallcup
and Beasley, 1987; Nishiyama et al., 1996), together with
anti-BrdU (Figure 3A). The proportion of BrdU-labeled
O-2A progenitors was high (about 75%) at E13 but
dropped steeply as the cell number increased, reaching
a stable low value (about 20%) between E17 and P3
(Figure 3A, black triangles). This suggested that the cell
cycle time increases substantially between E13 and E17.
To confirm this interpretation and to determine whether
the decrease in BrdU labeling results from slowing of
division in the progenitor cell population as a whole or
from segregation into rapidly and slowly dividing sub-
populations, we performed cumulative BrdU-labeling
experiments. Sequential BrdU injections were made into
pregnant mothers at 4 hr intervals starting on E14 or
E17, and the proportions of BrdU-labeled progenitors
were determined at various times after the first injection
as described above. At E14, essentially all of the progen-
itors could be labeled by sequential BrdU injections,
demonstrating that all of the progenitors were actively
engaged in the cell cycle (Figure 3B, left panel, black
triangles). The BrdU labeling index increased in a linear
fashion with time after first injection, providing evidence
Figure 3. The Progenitor Cell Division Cycle Slows Down Markedly
that the whole population of progenitors was cycling before Birth
together at the same rate. The same conclusionÐthat
(A) Pregnant female mice or young postnatal animals were given a
all the progenitors were cycling at the same rateÐwas single intraperitoneal injection of BrdU. The embryos or prewean-
also true at E17 (Figure 3B, right panel, black triangles). lings were killed 2 hr later, and dissociated spinal cord cells were
cultured on glass coverslips before immunolabeling with anti-NG2However, it took longer for the BrdU labeling index to
proteoglycan (a marker of oligodendrocyte progenitors) and anti-reach 100% at E17 than at E14, confirming that the cell
BrdU (upper and lower micrographs, respectively). BrdU1, NG21cycle slows down between E14 and E17 (Figure 3B,
double-positiveprogenitor cells (e.g. arrows) werecounted andplot-
compare left and right panels, black triangles). Thus, ted as a proportion of the total NG21 progenitor population. The
the cumulative BrdU labeling experiments confirm that BrdU labeling index fell from z80% to z20% between E13 and E17
the BrdU labeling index in the single-injection experi- in both wild-type (triangles) and hemizygous transgenic NSE-PDGF-
AS animals (squares), corresponding to an increase in cell cycle timements is indicative of cell cycle length. Making certain
from z6 hr to 22 hr (see Figure 3B and Experimental Procedures).reasonable assumptions, we can use the BrdU data to
Each data point represents the mean 6 SD of at least two and upcalculate approximate cell cycle times (see Nowakowski
to six animals (each in triplicate) from two litters.et al., 1989, and Experimental Procedures for details).
(B) Pregnant females were given sequential injections of BrdU at 4
We estimate that the cell cycle time increases from z6 hr intervals (vertical arrows) starting at E14 (left) or E17 (right), and
hr at E13 to z15 hr at E14 and then to z22 hr at E17 the BrdU labeling indices of NG2-positive progenitor cells deter-
mined as for Figure 3A. Close to 100% of progenitor cells can beand later.
labeled with BrdU both in wild-type (triangles) and hemizygousSince the cell cycle slows down markedly but does
transgenic NSE-PDGF-AS embryos (squares) at both E14 and E17,not stop, it seems likely that in order for proliferation
indicating that all of the progenitors were actively cycling at theseto stop, new cell production must be matched by cell
ages. The time taken for 100% of progenitors to label with BrdU
differentiation and/or death. We looked for dying pro- was longer in wild-type embryos than transgenic embryos at E14
genitor cells in sections of E15 and E17 spinal cord by in (left panel), indicating that the cell cycle is shorter in the transgenics
situ hybridization for PDGFRa combined with propidium at this age. The time taken for 100% of progenitors to label at E17
is longer than at E14, indicating that the cell cycle slows down afteriodide staining to visualize cell nuclei. At E15 we were
E14 in both wild types and transgenics. Moreover, the rate of BrdUunable to detect any PDGFRa1 progenitor cells with
incorporation (and hence the rate of cell division) is the same in wildpyknotic nuclei (i.e., undergoing apoptosis). However,
types and transgenics at E17 (z22 hr; see text and Experimental
we did detect small numbers of apoptotic progenitors Procedures for details). Each data point represents the mean 6 SD
at E17 (data not shown). As described later, we also from at least two and up to ten animals (each in triplicate) from one
detected small numbers of dying, immature oligoden- or two litters. Error bars are not shown where the SD is less than
the size of the symbol.drocytes in the wild-type cordat E17. Therefore, it seems
Oligodendrocyte Population Dynamics
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Figure 4. Expression of PDGF-A in Wild-
Type and NSE-PDGF-AS Transgenic Spinal
Cords
(A) RNase protection assays for PDGF-A tran-
script abundance in hemizygous NSE-PDGF-
AS transgenic and wild-type spinal cords.
Hybridization reactions contained either a
mixture of probes for endogenous (mouse)
and transgenic (human) PDGF-A or a probe
for GAPDH as a control for RNA amounts.
The undigested PDGF probes are shown on
the left. Protected fragments corresponding to
endogenous and transgene-derived PDGF-A
transcripts can be distinguished (mPDGF-A
and hPDGF-A, respectively). The human
PDGF-A probe did not cross-hybridize to en-
dogeneous mouse PDGF-A mRNA in a wild-
type embryo (P6 wt); comparison of lanes P6
and P6 wt also demonstrates that the pres-
ence of the transgene did not affect expres-
sion of the endogenous PDGF-A gene. Both
endogeneous and transgene-derived tran-
scripts are expressed from before E11 until
adulthood. The transgene was expressed at
a roughly constant level from E15 to P6,
whereas endogenous gene transcription in-
creased between E15 and P0 but did not
change much after that. The transgene was
expressed at a similar level to endogeneous
transcripts.
(B) Comparison of the spatial distributions of
endogenous and transgene-derived PDGF-A
transcripts. Sections through the spinal cords
of E15 wild-type (wt) or hemizygous NSE-
PDGF-AS transgenic (tg) mice were subjected
to in situ hybridization with DIG-labeled
probes for mouse or human PDGF-A. Cross-
hybridization of the human probe to endoge-
nous mouse transcripts was not a problem
under our assay conditions (compare center
and right panels). Both endogenous and transgene-derived PDGF-A transcripts are expressed widely throughout the spinal cord in many
neurons. Endogenous PDGF-A is most strongly expressed in motor neuron pools in the ventral horns, while the transgene is expressed more
strongly in the dorsal cord. Scale bar 5 100 mm.
likely that the reason progenitor cells stop proliferating binds to the extracellular matrix (e.g., Pollock and Rich-
ardson, 1992). Our transgenic mice express a Myc epi-before birth is because the cell cycle slows down mark-
edly, and this is accompanied by an increase in cell tope±tagged version of human PDGF-AS (Pollock and
Richardson, 1992). The generation of these mice has beendeath.
described previously (Fruttiger et al., 1996). RNase pro-
tection assays showed that the transgene is expressedProgenitor Cell Division Slows Down because PDGF
Becomes Limiting in the spinal cord from before E11 until adulthood (Figure
4A). The level of transgene-derived PDGF-AS mRNA wasWhy does the O-2A progenitor cell cycle slow down
before birth? We thought it possible that PDGF or other comparable to that of endogeneous PDGF-A after E15
(Figure 4A). RT±PCR also clearly revealed the presencemitogens might become limiting and cause cells to ac-
cumulate in G1, either because of a reduction in the of transgene-derived transcripts in addition to endoge-
neous PDGF-AS transcripts; PDGF-AL appeared not to beconcentration of extracellular mitogens or because of a
decline in thesensitivity of the cells to mitogenic stimula- expressed in the spinal cord (data not shown) or retina
(Fruttiger et al., 1996). In situ hybridization showed thattion. If so, boosting the mitogen supply by overexpress-
ing PDGF in transgenic mice might be expected to over- transgene-derived human PDGF-AS mRNA, like endo-
geneous PDGF-AS mRNA (Yeh et al., 1991), is expressedcome slowing of the cycle. We therefore examined
transgenic mice that overexpress PDGF-A in neurons widely throughout the embryonic spinal cordby neurons
(Figure 4B). The overall distributions of transgene-under the control of the neuron-specific enolase (NSE)
gene promoter (Forss-Petter et al., 1990). derived and endogenous PDGF-A transcripts were
therefore similar (Figure 4B). PDGF-A is also expressedThere are two natural alternative-splice isoforms of
PDGF-A: a short, freely diffusible form (PDGF-AS) and a in white matter astrocytes (Richardson et al., 1988; Prin-
gle et al., 1989; Yeh et al., 1991), but these cells arelong form (PDGF-AL) with a carboxy-terminal tail that
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labeling index of progenitors at E13 started at the same
high level (75%±80%) as in wild-type embryos but fell
after this, eventually declining to the same low value
(about 20%) as in the wild types (Figure 3A, open
squares). However, the decrease in labeling index was
more gradual in transgenics than in wild types, so that
there is a window of time between E13 and E17 when
the progenitors divide more rapidly in the transgenics
than in the wild types.
The fact that increasing the PDGF supply in the
transgenics has no effect on the progenitor cell cycle
at E13 (Figure 3A) but has a positive influence on the
cycle at E14 (Figures3A and 3B, left panel) demonstrates
that in wild-type mice the PDGF supply is saturating for
cell division at E13 but becomes limiting by E14. This
suggests that the cell cycle normally slows down either
because the extracellular PDGF concentration drops or
because the cells' responsiveness to PDGF declines.
Even in hemizygous transgenic mice, the supply of
PDGF eventually becomes limiting because doubling
the transgene copy number in homozygous transgenics
increases proliferation still further and generates yet
more cells at steady-state (around seven times normal in
homozygotes compared to three times in hemizygotes)
(Figure 5).
Excessive and Ectopic Production of
Oligodendrocytes in NSE-PDGF-AS
Transgenic Mice
Figure 5. PDGF Dose Dependency of O-2A Progenitor Proliferation To test whether the increased progenitor cell proliferation
In Vivo observed in NSE-PDGF-AS transgenic mice is matched
O-2A progenitors in P11 wild-type (top), hemizygous (middle), and by increased oligodendrocyte differentiation, we visual-
homozygous (bottom) NSE-PDGF-AS transgenic spinal cords were ized postmitotic oligodendrocytes in sections of spinal
visualized by in situ hybridization with a DIG-labeled probe for
cords from wild-type and hemizygous transgenic micePDGFRa. There are approximately three times the normal number
at different developmental stages by in situ hybridizationof progenitors in hemizygotes and seven times the normal number
with a probe for the myelin proteolipid protein PLP/DM-in homozygotes. Scale bar 5 100 mm.
20. At E17, when there were very few PLP/DM-20-posi-
tive oligodendrocytes in the wild-type spinal cord, there
were many oligodendrocytes in the transgenic cordnot generated in large numbers until after birth. Despite
much effort, we were unable to detect transgene- (data not shown). Overproduction of oligodendrocytes
was even more pronounced in E19 transgenic spinalderived PDGF-A polypeptides by immunohistochemis-
try in sections. This is probably because PDGF, a se- cords (Figure 6). Many of the excess oligodendrocytes
were abnormally located in the central gray matter, un-creted molecule, does not build to detectable levels
either inside cells or in the interstitial space. like oligodendrocytes in wild-type spinal cords that are
mainly located in the developing white matter at all ages.We compared numbers of O-2A progenitors in hemi-
zygous NSE-PDGF-AS transgenic mice and their wild- However, within one week, at P6, the situation appeared
to have resolved and the number and distribution oftype littermates by in situ hybridization with a probe to
PDGFRa as before (Figure 2). Up to E13.5, there was PLP/DM-20-expressing oligodendrocytes was normal
(Figure 6). A similar picture emerged when sections wereno noticeable difference in either the number or distribu-
tion of progenitor cells in the transgenics compared to probed for MBP mRNA rather than PLP/DM-20 mRNA
(Figure 6).their wild-type littermates. However, at E15 and after
there was a marked increase in the number of progenitor We counted the numbers of PLP/DM-20-positive oli-
godendrocytes in sections of wild-type, hemizygouscells in the transgenic cord (Figures 2A and 2B). The
number of O-2A progenitors in transgenic spinal cords transgenic, and homozygous transgenic P6spinal cords
and compared these with the numbers of PDGFRa-posi-reached a plateau before birth just as in wild-types,
except that there were more than three times the number tive progenitor cells in sections of E15 spinal cords.
Despite the z7-fold variation in the number of oligoden-of progenitor cells in the transgenics as in the wild-types
at steady-state (805 6 71 compared to 246 6 18, data drocyte progenitor cells, the number of mature oligoden-
drocytes did not change significantly (Figure 7). Thus,from four sections from each of two animals of each
genotype) (Figure 2B). Following single injections of progenitor cell number and oligodendrocyte number are
controlled independently of each other.BrdU into transgenic mothers, we found that the BrdU
Oligodendrocyte Population Dynamics
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Figure 6. Excessive and Ectopic Production
of Oligodendrocytes in NSE-PDGF-AS Spinal
Cords
Oligodendrocytes were visualized in sections
of spinal cord from wild-type (wt)and hemizy-
gous transgenic (tg) mice by in situ hybridiza-
tion with probes against MBP or PLP/DM-20
and photographed under dark-field illumina-
tion. At E19, there are many more MBP-posi-
tive, PLP/DM-20-positive oligodendrocytes
present in the transgenic spinal cord than in
the wild-type cord. Many of the extra oligo-
dendrocytes in the transgenics are found ec-
topically in the central gray matter of the cord.
However, within one week, at P6, this situa-
tion resolves and the number and distribution
of oligodendrocytes in the transgenic cord
appears normal. Scale bar 5 100 mm.
Elimination of Excess Oligodendrocytes pyknotic GC2 nuclei, possibly dying neurons, and a
much smaller number of pyknotic GC1 oligodendrocytesby Programmed Cell Death
It seemed possible that the superfluous oligodendro- (Figure 8B). In contrast, there were large numbers of
pyknotic GC1 oligodendrocytes in the hemizygous trans-cytes that developed before birth in the transgenic mice
might be cleared by programmed cell death (PCD). To genic spinal cords and an even greater number in the
homozygous transgenic cords, although there was notest this, we labeled E19 wild-type and transgenic spinal
cord sections with anti-galactocerebroside (anti-GC) to increase in the number of pyknotic GC2 cells in the
transgenics (Figure 8B). Many, but not all, of the dyingmark oligodendrocytes and with propidium iodide to
highlight pyknotic nuclei (Figure 8A). We counted the GC1 oligodendrocytes were in the central gray matter,
presumably corresponding to the ectopic MBP PLP/total number of pyknotic nuclei per section and the num-
ber of GC1 oligodendrocytes with pyknotic nuclei. In DM-20-positive oligodendrocytes that disappear be-
tween E19 and P6 (see Figure 6).wild-type spinal cord sections, we found a number of
Superfluous Oligodendrocytes Are Eliminated at a
Distinct Immature Stage of Differentiation
Further examination revealed that there were two dis-
tinct categories of PLP/DM-20-expressing cells in both
normal and transgenic spinal cords that could be distin-
guished on the basis of their in situ hybridization signal
intensities. This was most obvious when pairs of E19
and P6 spinal cord sections were processed for in situ
hybridization simultaneously under identical conditions
and viewed under bright-field rather than dark-field illu-
mination (Figure9). It then becameclear that the majority
of the ectopic oligodendrocytes that appeared in theFigure 7. The Number of Oligodendrocytes Surviving Postnatally Is
Independent of the Number of O-2A Progenitor Cells prenatal transgenic cords (see Figure 6) were of a type
that express relatively low levels of PLP/DM-20 tran-Numbers of PDGFRa1 progenitor cells in sections of wild-type (wt),
hemizygous transgenic (tg), and homozygous transgenic (tg/tg) E15 scripts compared to myelin-forming oligodendrocytes
spinal cords are displayed in comparison with the numbers of PLP/ in the P6 cord (Figure 9). Small numbers of these faint
DM-20-positive oligodendrocytes in sections of P6 cords (mean 6 PLP/DM-20-expressing cells could also be recognized
SD of a total of 8±12 sections from 2 or 3 animals of each genotype).
in wild-type E19 cords. It seems likely that these cellsDespite the z7-fold increase in the number of oligodendrocyte pro-
in both wild-type and transgenic cords represent newlygenitor cells in homozygous transgenic animals, the number of sur-
viving oligodendrocytes is completely normal. differentiated, immature oligodendrocytes that have not
Neuron
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Figure 8. Superfluous Oligodendrocytes in
NSE-PDGF-AS Transgenic Spinal Cords Are
Eliminated by Programmed Cell Death
(A) Sections of wild-type (wt), hemizygous
transgenic (tg), and homozygous transgenic
(tg/tg) E19 spinal cords were immunolabeled
with monoclonal anti-GC to visualize oligo-
dendrocytes and counterstained with propid-
ium iodide to reveal pyknotic nuclei charac-
teristic of apoptotic cells. The lower two
micrographs show a higher magnification
view (left, anti-GC; right, propidium iodide) of
the region indicated above by a single arrow.
Double-labeled cells (dying oligodendrocytes)
are indicated (arrows). Scale bars 5 100 mm
(top) and 20 mm (bottom).
(B) The total number of cells with pynotic nu-
clei as well as the number of GC1 oligoden-
drocytes with pyknotic nuclei were counted
in 15 mm sections. There were many more
GC1 pyknotic cells (dying oligodendrocytes)
in hemizygous transgenic cords (tg) than in
wild-type cords and even more in homozy-
gous transgenics (tg/tg). There were, how-
ever, no significant differences in the num-
bers of GC2 pyknotic cells in the transgenics
compared to wild type.
yet achieved their maximal levels of myelin gene expres- possessed pyknotic nuclei (data not shown), suggesting
that oligodendrocytes are continually being overpro-sion, perhaps because they have not managed to asso-
ciate with axons. It is these immature cells that are pref- duced and cut back by PCD throughout the embryonic
and early postnatal period.erentially eliminated by PCD.
With appropriate autoradiographic exposure times
(Figure 9), immature oligodendrocytes could also be de- Discussion
tected in P6 wild-type and transgenic spinal cords and
could be easily distinguished from more mature oligo- PDGF-AA Drives Proliferation of O-2A
Progenitors In Vivodendrocytes, mainly in white matter, that expressed
markedly higher levels of myelin gene products. The im- We investigated the control of proliferation of O-2A pro-
genitor cells in the developing spinal cord. By analyzingmature oligodendrocytes were more numerous in P6
transgenic cords than in wild-type cords and seemed transgenic knockout mice that lack either PDGF-A or
-B chains, we showed that PDGF-AA homodimers areto be preferentially located in the central gray matter,
as at earlier ages (Figure 9, arrows).A proportion of these crucial for proliferation of these cells during normal de-
velopment, although PDGF was not required for initialimmature oligodendrocytes in P6 transgenic cords also
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Figure 9. Excess Oligodendrocytes Die at an
Early Stage of Differentiation
Sections of wild-type (wt), hemizygous trans-
genic (tg), and homozygous transgenic spinal
cords (tg/tg) were subjected to in situ hybrid-
ization with a probe against PLP/DM-20
mRNA and visualized by autoradiography (3
days exposure time) and bright-field micros-
copy. Sections from E19 (left column) and P6
(right column) spinal cords were processed
andexposed in parallel under identical condi-
tions so that the in situ signal intensities are
directly comparable in all sections. There are
two distinct populations of oligodendrocytes
that can be distinguished on the basis of their
PLP/DM-20 signal intensity. This is most
obvious in the transgenic spinal cords; oligo-
dendrocytes in the ventral and dorsal white
matter of the P6 cords express PLP/DM-20
transcriptsstrongly (large arrowhead), whereas
many oligodendrocytes in the central gray
matter of the P6 cords as well as the majority
of oligodendrocytes in the E19 cords express
PLP/DM-20 at a much lower level (small
arrows). The latter faint cells probably repre-
sent young (i.e., recently formed) oligoden-
drocytes that have not yet accumulated maxi-
mal levels of myelin gene products. It is these
faint oligodendrocytes mainly in the central
regions of the transgenic cords that are elimi-
nated by PCD (compare Figures 6 and 8).
Small numbers of faint, newly formed oligo-
dendrocytes can also be observed in wild-
type spinal cords at both E19 and P6, arguing
that continuous production and elimination
of superfluous and ectopic oligodendrocytes
is a normal featureof late embryonic and early
postnatal development that is greatly exagger-
ated in the transgenic animals.
lineage specification. In contrast, PDGF-B seems to be z22 hr. This slowdown, together with an increase in cell
death, results in the arrest of progenitor cellproliferation.unimportant for O-2A progenitor proliferation during de-
velopment. PDGF-B is expressed by capillary endothe- Slowing of the cell cycle is a common feature of progeni-
tor cell populations in the developing CNS. For example,lial cells in the CNS from early embryonic ages until
adulthood (Mudhar et al., 1993; Lindahl et al., 1997); Caviness and colleagues found that the cycle time of
neural precursors in the mouse cerebral cortex length-presumably, this PDGF-B is not available to O-2A pro-
genitors. After birth, many neurons start to express low ens from z8 hr to z24 hr between E11 and E17, with
almost all variation falling within G1 (Takahashi et al.,amounts of PDGF-B (Sasahara et al., 1991), but we have
been unable to assess the role of PDGF-B in the postna- 1994, 1995).
Overexpressing PDGF in transgenic mice delayed de-tal CNS because the knockout mice die at birth.
Many previous studies have shown that PDGF stimu- celeration of the O-2A progenitor cell cycle, causing a
transient increase in the cell division rate compared tolates O-2A progenitor proliferation in vitro (e.g., Noble
et al., 1988; Raff et al., 1988; Richardson et al., 1988; normal and an increase in the final number of progenitors
at steady-state. This demonstrates that progenitor cellLevine, 1989); we have now shown that PDGF is crucial
for proliferation in vivo. Note that our results do not imply divisions are normally limited by the PDGF supply. There
is evidence from in vitro studies that the cell cycle timethat PDGF is the only growth factor that is important in
vivo; PDGF might normally act in concert with other of O-2A progenitors is dependent on the concentration
of PDGF in the medium (Gao and Raff, 1997; P. vanfactors (e.g., glial growth factor or neurotrophin-3) (Bar-
res et al., 1994; Canoll et al., 1996) whose combined Heyningen and W. D. R., unpublished data). In addition,
it is known that the duration of the cell cycle in fibroblastaction might be required for maximal cell proliferation
in vivo. cultures is controlled by the concentration of mitogens,
including PDGF (Shields and Smith, 1977; Brooks and
Riddle, 1988).Progenitor Cell Division Is Normally Limited
by the PDGF Supply Another indication that PDGF might be in limiting sup-
ply during CNS development comes from the experi-We found that theO-2A progenitor cell cycle slowsdown
markedly before birth in normal embryos, from z6 hr to ments of Gard and Pfeiffer (1993), who reported that
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oligodendrocyte progenitors isolated directly from early most of them die and are cleared before they have the
chance to express detectable amounts of myelin genepostnatal rat cerebrum transiently reverted to a less
mature state of differentiation when exposed to saturat- products.
ing concentrations of PDGF in vitro. This implies that
the progenitors had beenexposed to subsaturating con-
Overproduction and Elimination of Immaturecentrations of PDGF in vivo, prior to isolation.
Oligodendrocytes by ProgrammedOur finding that PDGF overexpression causes a tran-
Cell Deathsient increase in progenitor cell division rate seems in-
Oligodendrocytes were generated in excess and atconsistent with a previous in vivo study (Barres et al.,
ectopic sites in the gray matter of NSE-PDGF-AS trans-1992a) in which exogenous PDGF-AA was delivered to
genic spinal cords. Most of these ectopic oligodendro-the postnatal rat optic nerve. This resulted in increased
cytes were eliminated at an immature stage of differenti-numbers of immature oligodendrocytes but no apparent
ation by PCD, resulting in a completely normal numberincrease in progenitor cell division. It is questionable
and distribution of myelinating oligodendrocytes by thewhether Barres et al. (1992a) would have detected a
end of the first postnatal week. Dying, immature oli-transient effect in their experiments. Moreover, it is likely
godendrocytes could be detected in the gray matterthat the cell cycle had already slowed down before
of the transgenic spinal cord from before E17 until atPDGF was administered in the experiments of Barres
least P6. Small numbers of dying, immature oligoden-et al. (1992a), and it is not known whether this is easily
drocytes could also be detected in wild-type spinalreversible. Intracellular changes that orchestrate slow-
cords throughout this period, suggesting that overpro-ing of the cell cycle (e.g., changes in the levels of cyclins
duction and elimination of immature oligodendrocytesand CDK inhibitors; Sherr and Roberts, 1995; Casac-
in gray matter is a normal developmental process thatchio-Bonefil et al., 1997; Durand et al., 1997) might be
is greatly exaggerated in the transgenic mice. Therefore,self-reinforcing and put a permanent brake on the cycle.
it appears likely that the reason mature myelinating oli-Why should PDGF, which is initially present in saturat-
godendrocytes normally accumulate selectively in whiteing amounts, later become limiting for cell division? Pos-
matter is not that progenitor cells differentiate preferen-sible explanations are that 1) the concentration of PDGF
tially in fiber tracts as recently suggested (Hardyand Fried-in the extracellular space falls, perhaps due to increased
rich, 1996); rather, they leave the cell cycle and start toconsumption by the increasing population of progeni-
differentiate in both gray and white matter, but theirtors; 2) the intrinsic sensitivity of the progenitor cells
progeny mature and survive long-term predominantlyto mitogenic stimulation by PDGF declines; or 3) the
within white matter.concentration of a PDGF antagonist or a general anti-
It is worth remembering that the number of apoptoticmitogenic factor such as TGFb rises. We are currently
cells that can be detected at any given moment dependstrying to distinguish among these possibilities.
not only on the rate of cell death (i.e., number of cells
that die per unit time) but also on the rate at which dead
or dying cells are cleared by phagocytosis. We suspectStochastic Exit from the Cell Cycle and Initiation
of Oligodendrocyte Differentiation that both the rate of cell death and the clearance rate
might increase in the transgenic cords because the num-Progenitor cell number stops increasing before birth
despite the fact that they continue to divide about once ber of apoptotic oligodendrocytes is increased about
10-fold in the hemizygous transgenics and 30-fold ina day. It follows that production of new progenitor cells
must be balanced by cell differentiation, cell death, or the homozygotes, although the number of progenitor
cells is increased only 3-fold and 7-fold, respectively.both. We favor the idea that half of the newly formed
progenitor cells exit from the cell cycle each generation This suggests that normal clearance mechanisms might
beoverwhelmed by the increased numberof dying oligo-and initiate oligodendrocyte differentiation. This is by
analogy with the behavior of 3T3 fibroblasts growing in dendrocytes in the transgenics. If clearance rates were
increased nonuniformly across the transgenic cord, thissuboptimal concentrations of mitogens in vitro. When
these cells were grown in 2% newborn calf serum, alone could explain the uneven distribution of apoptotic
oligodendrocytes that we observe without the need toz20% of the cells left the cycle (entered G0) each gener-
ation; in 1% serum, the proportion was closer to 30% invoke nonuniform oligodendrocyte differentiation and
death.(Brooks and Riddle, 1988). Because 3T3 cells are an
immortal line of identical cells, the decision whether Immature, dying oligodendrocytes were not confined
to gray matter. There were also large numbers of theseto exit the cell cycle or to continue cycling must be a
stochastic one. cells in the developing white matter of transgenic spinal
cords and smaller numbers in wild-type cords. This isSince O-2A progenitors appear to experience subsat-
urating concentrations of mitogens in vivo (see above), consistent with previous studies of developing fiber
tracts. Barres et al. (1992a) showed that z50% of allit seems plausible that they should behave in an analo-
gous manner to serum-deprived fibroblasts; that is, a oligodendrocytes formed in the normal developing rat
optic nerve are eliminated by PCD soon after they arefraction of the progenitors exits the division cycle each
generation, enters G0, and starts to differentiate. At formed. More recently, Trapp et al. (1997) showed that
many oligodendrocytes in brain fiber tracts also die atsteady-state, when the number of progenitors is stable,
this fraction would be exactly half. We believe for rea- an immature developmental stage when they express
DM-20 but not yet PLP. We presume that the dying,sons given below that large numbers of oligodendro-
cytes cannot normally be detected before birth because faintly PLP/DM-20-positive oligodendrocytes that we
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see in the spinal cord correspond to this (DM201, PLP2) It is known that axons are required for long-term survival
of oligodendrocytes (Barres and Raff, 1994), but whyclass of premyelinating oligodendrocytes, but this re-
mains to be tested. As has previously been pointed out survival signals should start to appear specifically in
ventral axon tracts around birth is a mystery.(Barres et al.,1994; Burneet al., 1996; Casacchio-Bonefil
et al., 1997), axonal regulation of oligodendrocyte sur- An alternative explanation for the stabilization of pro-
genitor cell number before birth might be that half of thevival might be a simple strategy for ensuring that oligo-
dendrocytes are matched to the surface of axons requir- progenitors drop out of division each cycle and remain
dormant as PDGFRa-negative, PLP/DM-20-negativeing to be ensheathed.
cells until the appearance of oligodendrocyte matura-
tion±inducing factors around birth. We think this is un-
The Time of Appearance of Myelinating likely for three reasons. First, there is little evidence
Oligodendrocytes in the Spinal Cord for the existence of a (PDGFRa, PLP/DM-20)-negative
Depends on Timed Survival Cues, phenotypic stage in oligodendrocyte lineage progres-
Not Timed Differentiation sion. O-2A progenitors can be induced to differentiate
It has been proposed that the first appearance of differ- into (PDGFRa, PLP/DM-20)-negative type-2 astrocytes
entiated oligodendrocytes in vivo is timed by a progeni- in vitro, but these cells have not been identified in vivo
tor cell±intrinsic clock that causes progenitors to exit (Fulton et al., 1991) and rather few astrocytes develop
the cell cycle and differentiate into oligodendrocytes in the prenatal spinal cord in any case. Second, from
after a predetermined period of time (Raff et al., 1985; the numbers quoted above we can calculate that a large
Temple and Raff, 1986; Durand et al., 1997; Gao et al., number of these putative (PDGFRa, PLP/DM-20)-nega-
1997). This is suggested by the fact that O-2A progenitor tive cells, z1,000 cells/10 mm section, would have to
cells from rat optic nerves do not proliferate indefinitely accumulate in the normal spinal cord before birth (and
invitro even in thepresence of saturating concentrations many more in the transgenics). This is more than the
of PDGF or other mitogens; the clonal progeny of a combined total of progenitors and mature oligodendro-
single optic nerve O-2A progenitor tend to stop dividing cytes in theP6 spinal cord (z200±250of each; see Figure
and differentiate together into oligodendrocytes after a 7). Third, we can detect small numbers (around three
maximum of about eight cell divisions (Temple and Raff, per section) of both dying PDGFRa1 progenitor cells
1986). However, differentiation of O-2A progenitors from and dying, immature oligodendrocytes in the normal
rat spinal cord or cerebral cortex seems not to be gov- prenatal spinal cord; if their clearance time is similar to
erned by a simple intracellular timer, because the clonal that estimated in the developing optic nerve (z1 hr;
progeny of these cells do not necessarily differentiate Barres et al., 1992a), then this alone could account for
synchronously into oligodendrocytes after a set period the majority of the missing oligodendrocyte lineage cells.
of cell division in vitro (Zhang and Miller, 1995; Ibarrola
et al., 1996). Our in vivo data also seem inconsistent with
a simple cell-intrinsic timing mechanism that determines Population Dynamics of Oligodendrocyte
Development: A Modelwhen mature oligodendrocytes first appear in the spinal
cord. Most previous studies of oligodendrocyte development
have been conducted in vitro. Our transgenic studiesDying, immature oligodendrocytes are present in the
spinal cords of our NSE-PDGF-AS transgenic mice for complement and extend those in vitro studies and pro-
vide some insights into the developmentof theoligoden-several days before myelin-forming oligodendrocytes
start to appear around birth. Small numbers of dying, drocyte lineage in vivo. On the basis of our findings,
we can begin to construct a model of the populationimmature oligodendrocytes can also be detected in
wild-type cords, suggesting that this is a normal feature dynamics of oligodendrocyte development (see Figure
10). The essential features of this model are as follows:of development that is greatly exaggerated in the trans-
genic mice, perhaps in part because clearance of dead 1) numbers of progenitor cells and mature oligodendro-
cytes are controlled separately, progenitors by competi-cells is slower in the transgenics (see above). We know
from the number of progenitor cells in a 10 mm section tion for limited supplies of PDGF and possibly other
mitogens, oligodendrocytes by competition for limitedof wild-type late embryonic spinal cord (z230) and the
calculated cell cycle time (z22 hr) that over 200 new supplies of survival factors. These ideas have been dis-
cussed before (e.g., Barres et al., 1992b; Burne et al.,progenitor cells must be generated each day per 10 mm
section. Since progenitor cell number does not increase 1996) but gain strong support from the present study. 2)
Exit from the cell cycle and initiation of oligodendrocytemuch after E15 and mature oligodendrocytes do not
appear in significant numbers until after birth, we con- differentiation is a stochastic process, depending on the
probability per unit time of a progenitor cell's leavingclude that over 200 cells/day/section normally die during
late embryonic development either as progenitor cells the division cycle and entering G0 relative to its probabil-
ity of entering the next S-phase. As mitogenic signalingor newly differentiating oligodendrocytes. Only a very
small proportion of these can be detected, presumably intensity decreases and the cell cycle slows down, the
likelihood of a cell dropping into G0 increases. Eventu-because the dead cells are cleared rapidly. Neverthe-
less, it seems possible that the reason more mature ally, the number of cells that exits the cycle each genera-
tion becomes equal to the number that enters a newoligodendrocytes start to appear around birth is not that
they start to differentiate (i.e., become postmitotic) at cycle, and net progenitor cell proliferation ceases. 3)
The time of first appearance of mature oligodendrocytesthat time; rather, they are generated continuously for





Production and genotyping of transgenic NSE-PDGF-AS mice has
been described (Fruttiger et al., 1996). Transgene expression was
analyzed by RNase protection essentially by the method of Melton
et al. (1984). Protected RNA fragments were separated on a 6% (w/v)
polyacrylamide sequencing gel and subjected to autoradiography.
Tissue Preparation and In Situ Hybridization
Our in situ hybridization procedures have been described (Pringle et
al., 1996). For quantitative comparisons among different specimens,
two or three spinal cords were aligned, frozen side by side, and
sectioned simultaneously to standardize section thickness.
Cell Cycle Analysis In Vivo by BrdU Injection
Pregnant females or postnatal pups were injected intraperitoneally
with 50 mg BrdU per gram of body weight, injected at 10 mg/ml in
phosphate-buffered saline. This concentration of BrdU was pre-Figure 10. A Tentative Model of Spinal Cord Oligodendrocyte De-
viously found to be nontoxic for rapidly proliferating E14 corticalvelopment Derived from the Transgenic Studies Described in This
precursor cells in vivo (Nowakowski et al., 1989). For single-injectionPaper and Incorporating Ideas from the Previous Work of Ourselves
experiments, animals were killed 2 hr after injection, the spinal cordsand Others
dissected, and dissociated cells cultured overnight before labeling
Time runs from top to bottom (not to scale). Oligodendrocyte pro-
with anti-NG2 and anti-BrdU antibodies. Cells from individual ani-
genitors are specified in the ventral ventricular zone of the spinal mals were cultured separately (three coverslips per animal) as de-
cord and are first recognized by virtue of their expressionof PDGFRa scribed (Hall et al., 1996). Genotypes were determined retrospec-
on E12.5 in the mouse (E14 in rat). This is a direct or indirect effect tively. The 2 hr chase period following injection was chosen because
of signals, including Sonic hedgehog, from the notochord and/or maximum labeling was achieved within this period. Reducing the
floor plate (reviewed by Miller, 1996; Richardson et al., 1997). O-2A chase period to 15 min and culturing the cells for only 3 hr did not
progenitors proliferate rapidly at first (6 hr cell cycle) in response qualitatively change the outcome of the single-injection experiments
to PDGF-AA and migrate throughout the spinal cord to become (data not shown). The cumulative labeling experiments consisted
more or less evenly distributed in both gray and future white matter. of consecutive injections at 4 hr intervals followed by a 2 hr chase
As they increase in number, their division rate slows down (denoted before killing the animals.
by longer time lines), so that by E17 their division cycle stabilizes We can make a rough estimate of the cell cycle time TC from theat around 24 hr. With the lengthening cell cycle, cells spend longer cumulative labeling experiments (Nowakowski et al., 1989). In such
in G1 and the probability of their dropping out of cycle into G0 experiments there is a linear increase in the proportion of cells
and differentiating into oligodendrocytes increases relative to the labeled (labeling index, L) with increasing exposure to BrdU until all
probability of their entering the next division cycle. When the number
the cells in the growing fraction (in our case, 100%) are labeled. If
of progenitors that drops out of division each cycle matches the
the time taken to achieve maximum labeling is T and the length of
number that reenters S-phase, progenitor cell number reaches
S phase TS, then TC 5 T 1 TS. Forembryonic mousecortical precursorsteady-state (i.e., proliferation ceases); this happens between E15 cells, TS is invariant and close to 4 hr (Takahashi et al., 1995). Assum-and E17 in wild-type mice. At first, the newly differentiating oligoden- ing that TS for O-2A progenitors is the same, then our experimentsdrocytes die for lack of survival factors. Starting around birth, they indicate that the cell cycle time TC is z14 hr at E14, increasing tostart to survive and accumulate, mainly in developing white matter.
z22 hr at E17 (Figure 3B). In the single-injection experiments, the
Numbers of progenitor cells (circles) and surviving oligodendrocytes labeling index L 5 TS/TC, ignoring the small correction needed for(diamonds) are illustrative only. Dying, immature oligodendrocytes the fact that the BrdU pulse is not instantaneous. From these data
are denoted by a cross over the symbol. (Figure 3A) we can estimate that the cell cycle time is roughly 6 hr
at E13, 15 hr at E14, and 24 hr at E17, consistent with the multiple
injection experiments. Simply counting progenitors in sections of
embryonic mouse spinal cord yields average cell cycle times of z6generated but rather when they first start to mature
hr at E12.5±13.5 and z16 hr at E13.5±15 (Figure 2), again consistentand survive long-term due to the timed appearance of
with the other estimates.maturation/survival factors. Likewise, the distribution of
oligodendrocytes depends onthe distribution of survival
Antibody Labelingand/or maturation factors, not localized differentiation
Cryosections of fixed tissue or cells cultured on coverslips wereper se.
immunolabeled by conventional procedures. Monoclonal antibody
This model attempts to combine ideas from our pres- (N11.4) against the mouse and rat NG2 proteoglycan core protein
ent in vivo study and many previous in vitro studies; we were obtained from William Stallcup (Burnham Institute, La Jolla,
propose it tentatively as a focus for further debate and CA). For BrdU labeling, monclonal BU209 (Magaud et al., 1989) was
used. Monoclonal anti-GC was obtained from Martin Raff (Universityexperimentation. The dynamics of O-2A progenitor cell
College London). Propidium iodide (Sigma) was used to identifyproliferation and their conversion into differentiated oli-
pyknotic cell nuclei in sections.godendrocytes is complex and much remains to be
learned; however, a clear conclusion of the present
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